Patents by Inventor Elena Aleksandrovna MAKSIMENKO

Elena Aleksandrovna MAKSIMENKO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CDK8/19 inhibitors
    Patent number: 11840531
    Abstract: The present invention relates to novel compounds of formula I: which have the properties of CDK8/19 inhibitors, to a pharmaceutical composition comprising said compounds, and to use thereof as a medicine for treating diseases and disorders.
    Type: Grant
    Filed: July 31, 2019
    Date of Patent: December 12, 2023
    Inventors: Aleksei Leonidovich Mindich, Anna Jur'evna Chestnova, Mariia Andreevna Kasatkina, Andrei Ivanovich Alafinov, Aleksei Sergeevich Gavrilov, Anton Aleksandrovich Evdokimov, Liliana Vyacheslavovna Lenshmidt, Elena Aleksandrovna Maksimenko, Mariia Sergeevna Mishina, Sergei Aleksandrovich Silonov, Evgenii Jur'evich Smirnov, Pavel Andreevich Iakovlev, Dmitry Valentinovich Morozov
  • NOVEL CDK 8/19 INHIBITORS
    Publication number: 20220098160
    Abstract: The present invention relates to novel compounds of formula (1), which have the properties of a CDK8/19 inhibitor, and to a pharmaceutical composition containing said compounds, and to the use of said compounds and composition as pharmaceutical preparations for treating diseases or disorders.
    Type: Application
    Filed: February 28, 2019
    Publication date: March 31, 2022
    Inventors: Aleksei Leonidovich MINDICH, Svetlana Leonidovna GORBUNOVA, Aleksandra Vladimirovna POPKOVA, Artsiom Evgenievich SHEKHAUTSOU, Andrei Ivanovich ALAFINOV, Mariia Andreevna KASATKINA, Natalia Vladimirovna KOZHEMYAKINA, Anna Sergeevna KUSHAKOVA, Elena Aleksandrovna MAKSIMENKO, Leonid Evgen`evich MIKHAYLOV, Mariia Sergeevna MISHINA, Anna Jur'evna CHESTNOVA, Dmitry Valentinovich MOROZOV
  • CDK8/19 INHIBITORS
    Publication number: 20210246138
    Abstract: The present invention relates to novel compounds of formula I: which have the properties of CDK8/19 inhibitors, to a pharmaceutical composition comprising said compounds, and to use thereof as a medicine for treating diseases and disorders.
    Type: Application
    Filed: July 31, 2019
    Publication date: August 12, 2021
    Inventors: Aleksei Leonidovich MINDICH, Anna Jur'evna CHESTNOVA, Mariia Andreevna KASATKINA, Andrei Ivanovich ALAFINOV, Aleksei Sergeevich GAVRILOV, Anton Aleksandrovich EVDOKIMOV, Liliana Vyacheslavovna LENSHMIDT, Elena Aleksandrovna MAKSIMENKO, Mariia Sergeevna MISHINA, Sergei Aleksandrovich SILONOV, Evgenii Jur'evich SMIRNOV, Pavel Andreevich IAKOVLEV, Dmitry Valentinovich MOROZOV
  • Epidermal growth factor receptor inhibitors
    Publication number: 20200339544
    Abstract: The present invention relates to novel compounds of formula I, or pharmaceutically acceptable salts, solvates or stereoisomers thereof, also to a pharmaceutical composition, a method for inhibiting biological activity of epidermal growth factor receptor (EGFR), a method for treating diseases or disorders mediated by the activation of EGFR and use of the present compounds or the present pharmaceutical composition for the treatment of a disease or disorder mediated by the activation of EGFR.
    Type: Application
    Filed: October 5, 2018
    Publication date: October 29, 2020
    Inventors: Kirill Vadimovich ZAVIALOV, Svetlana Leonidovna GORBUNOVA, Artsiom Evgenievich SHEKHAUTSOU, Mariia Andreevna KASATKINA, Daria Dmitrievna BEKETOVA, Natalia Vladimirovna KOZHEMYAKINA, Kirill Igorevich KULISH, Elena Aleksandrovna MAKSIMENKO, Marina Viktorovna MELESHINA, Olga Anatolevna MELCHAEVA, Aleksei Leonidovich MINDICH, Dmitry Valentinovich MOROZOV, Aleksandra Vladimirovna POPKOVA, Ilia Alexeevich SMETANIN, Sergey Aleksandrovich SILONOV, Iaroslavna Alexandrovna SOLDATOVA, Georgii Viktorovich IAKOBSON